Everyone over 55, without any particular pathology or comorbid condition, can make an appointment since Monday with their doctor or pharmacy for an AstraZeneca or Johnson & Johnson shot.

An expansion that has not significantly increased the rate of vaccination, according to pharmacies and the Doctolib platform.

France has taken a new step in its vaccination campaign against Covid-19.

Since Monday, people over 55 without comorbidity can be vaccinated with the serums of AstraZeneca and and Johnson & Johnson.

On the other hand, this new age group has for the moment the right to be bitten only in pharmacies and in general practitioners.

Not enough to significantly increase the rate of vaccination.

>> LIVE -

Coronavirus: follow the evolution of the situation Tuesday, April 13

This expansion of the vaccination campaign has not yet been felt in terms of making appointments.

According to Stanislas Niox-Château, the founder of Doctolib, the platform is running at full speed, but not thanks to the opening of vaccination to people over 55 years old.

"It's going to be very gradual," he says.

Lack of supplies, "it doesn't change much"

No runaway either in pharmacies, where it will mainly be a question of selling the stocks already available.

Mirène runs a pharmacy in Boulogne-Billancourt.

For several weeks she has already had a list of people over 55 who are candidates for the vaccine.

She still had to have something to prick them.

"It depends on the number of doses we receive, and as we receive them in a dropper, we call people as and when we have doses," explains the pharmacist. 

“We vaccinate on Wednesdays and Fridays, and this week is already full” with previous reservations, also tells Mohammed Telha, the manager of the large pharmacy at Les Halles in Lille.

This opening to all over 55 years "gives more visibility", but "in town, that does not change much", for lack of sufficient supplies, adds the president of the URPS pharmacists of Hauts-de-France and UDI regional advisor, Grégory Tempremant.

The other two vaccines that use messenger RNA technology, Pfizer / BioNTech and Moderna, will be open to people over 60 from this Friday, while France is to receive a first delivery of 200,000 doses of Johnson & Johnson vaccines. this week.